The effect of fluvoxamine on new coronary pneumonia

The effect of fluvoxamine on new coronary pneumonia

Scientists said that in view of the latest research data and the long-term safety and universality of fluvoxamine, this may open a new door for the global treatment of new coronary pneumonia. At present, the research team has shared the results of this study with the National Institutes of Health (NIH), hoping that this drug will appear in the treatment recommendations of the World Health Organization.

According to reports, the expert group responsible for formulating guidelines for the treatment of new coronary pneumonia in the United States has listened to relevant information in mid-September and may soon decide whether to recommend fluvoxamine as an early treatment drug.